Monthly publication of Theraclion voting rights

Theraclion, a MedTech company located in Malakoff, France, has published its monthly voting rights report dated September 30, 2025. Listed on Euronext Growth Paris, the company has declared a total of 58,081,079 shares comprising its share capital. The theoretical number of voting rights reaches 72,881,292, including shares without voting rights. The actual number of voting rights amounts to 72,139,083, reflecting the rights exercisable at a general meeting.

This report includes the conversions of convertible bonds subscribed at the beginning of the year and stock warrants issued in June 2023. Theraclion, eligible for the PEA-PME, continues to commit to medical innovation with its robotic echotherapy platforms.